Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3732730
Max Phase: Preclinical
Molecular Formula: C24H27Cl2N3O2
Molecular Weight: 460.41
Molecule Type: Small molecule
Associated Items:
ID: ALA3732730
Max Phase: Preclinical
Molecular Formula: C24H27Cl2N3O2
Molecular Weight: 460.41
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ncc(Cl)cc1C(=O)N[C@H]1CC[C@H](CN2C(=O)C(C)(C)c3cccc(Cl)c32)CC1
Standard InChI: InChI=1S/C24H27Cl2N3O2/c1-14-18(11-16(25)12-27-14)22(30)28-17-9-7-15(8-10-17)13-29-21-19(5-4-6-20(21)26)24(2,3)23(29)31/h4-6,11-12,15,17H,7-10,13H2,1-3H3,(H,28,30)/t15-,17-
Standard InChI Key: KCPHVCVRMSDLQN-JCNLHEQBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 460.41 | Molecular Weight (Monoisotopic): 459.1480 | AlogP: 5.31 | #Rotatable Bonds: 4 |
Polar Surface Area: 62.30 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.97 | CX Basic pKa: 2.68 | CX LogP: 4.45 | CX LogD: 4.45 |
Aromatic Rings: 2 | Heavy Atoms: 31 | QED Weighted: 0.67 | Np Likeness Score: -1.17 |
1. (2011) Cyclohexyl amide derivatives as CRF receptor antagonists, |
Source(1):